PGNYProgyny, Inc.

Nasdaq progyny.com


$ 21.18 $ 0.14 (0.67 %)    

Monday, 19-Aug-2024 15:59:59 EDT
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 21.18
$ 21.15 x 100
$ 21.18 x 200
-- - --
$ 19.60 - $ 42.08
1,465,450
na
2.07B
$ 1.31
$ 33.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-06-2021 06-30-2021 10-Q
14 05-07-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-10-2020 12-31-2019 10-K
20 12-06-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-overweight-on-progyny-lowers-price-target-to-31

JP Morgan analyst Anne Samuel maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $41 to $31.

 btig-downgrades-progyny-to-neutral

BTIG analyst David Larsen downgrades Progyny (NASDAQ:PGNY) from Buy to Neutral.

 jmp-securities-maintains-market-outperform-on-progyny-lowers-price-target-to-31

JMP Securities analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and lowers the price tar...

 cantor-fitzgerald-maintains-overweight-on-progyny-lowers-price-target-to-37

Cantor Fitzgerald analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $48...

 truist-securities-maintains-buy-on-progyny-lowers-price-target-to-33

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $37 to...

 canaccord-genuity-downgrades-progyny-to-hold-lowers-price-target-to-24

Canaccord Genuity analyst Richard Close downgrades Progyny (NASDAQ:PGNY) from Buy to Hold and lowers the price target from $...

 leerink-partners-downgrades-progyny-to-market-perform-lowers-price-target-to-25

Leerink Partners analyst Michael Cherny downgrades Progyny (NASDAQ:PGNY) from Outperform to Market Perform and lowers the pr...

 progyny-q2-2024-adj-eps-043-beats-017-estimate-sales-30409m-miss-30542m-estimate

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.17 by 152....

 jmp-securities-initiates-coverage-on-progyny-with-market-outperform-rating-announces-price-target-of-36

JMP Securities analyst Constantine Davides initiates coverage on Progyny (NASDAQ:PGNY) with a Market Outperform rating and a...

 progyny-reports-acquisition-of-berlin-based-fertility-benefits-platform-apryl-no-terms-disclosed

This acquisition enhances Progyny's guided, concierge support that enables employees around the world to navigate the compl...

 truist-securities-maintains-buy-on-progyny-lowers-price-target-to-37

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $46 to...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION